ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
22.58
+0.42 (1.90%)
Mar 9, 2026, 4:00 PM EDT - Market closed

ACADIA Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
391226.45-61.29-215.98-167.87
Upgrade
Depreciation & Amortization
11.7615.885.552.033.34
Upgrade
Loss (Gain) From Sale of Assets
--146.52---
Upgrade
Loss (Gain) From Sale of Investments
-5.42-9.3-12.12-6.280.08
Upgrade
Stock-Based Compensation
52.1467.0566.4268.263.62
Upgrade
Other Operating Activities
-249.88----
Upgrade
Change in Accounts Receivable
-22.72-0.47-36.072.17-16.12
Upgrade
Change in Inventory
-18.2-49.55-28.812.42-4.21
Upgrade
Change in Accounts Payable
-5.29-1.354.85.87-1.62
Upgrade
Change in Other Net Operating Assets
-43.5555.5378.2227.54-2.88
Upgrade
Operating Cash Flow
109.84157.7216.7-114.04-125.66
Upgrade
Operating Cash Flow Growth
-30.36%844.31%---
Upgrade
Capital Expenditures
-4.69-0.52-0.05--1.12
Upgrade
Sale of Property, Plant & Equipment
-146.52---
Upgrade
Investment in Securities
-199.04-176.5372.0573.24-69.98
Upgrade
Other Investing Activities
-98.84--40--
Upgrade
Investing Cash Flow
-302.56-30.543273.24-71.1
Upgrade
Issuance of Common Stock
49.886.8525.138.218.16
Upgrade
Financing Cash Flow
49.886.8525.138.218.16
Upgrade
Foreign Exchange Rate Adjustments
0.03-0.09-0.020.010.01
Upgrade
Net Cash Flow
-142.82133.9373.81-32.59-178.59
Upgrade
Free Cash Flow
105.15157.216.65-114.04-126.78
Upgrade
Free Cash Flow Growth
-33.11%844.01%---
Upgrade
Free Cash Flow Margin
9.81%16.41%2.29%-22.05%-26.19%
Upgrade
Free Cash Flow Per Share
0.620.940.10-0.70-0.79
Upgrade
Cash Income Tax Paid
25.1719.525.852.191.04
Upgrade
Levered Free Cash Flow
-54.82270.0868.44-34.96-65.26
Upgrade
Unlevered Free Cash Flow
-54.82270.0868.44-34.96-65.26
Upgrade
Change in Working Capital
-89.764.1618.1337.99-24.82
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.